New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS).

Autor: Oba A; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Del Chiaro M; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA., Satoi S; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department Surgery, Kansai Medical University, Osaka, Japan., Kim SW; Department Surgery, Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea., Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yu J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA., Hioki M; Department of Surgery, Fukuyama City Hospital, Hiroshima, Japan., Tanaka M; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Kato Y; Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan., Ariake K; Department of Surgery, Tohoku University, Sendai, Japan., Wu YHA; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, USA., Inoue Y; Department of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi Y; Department of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Hackert T; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany., Wolfgang CL; Department of Surgery, New York University Langone Health, New York, New York, USA., Besselink MG; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schulick RD; Division of Surgical Oncology, Department of Surgery, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA., Nagakawa Y; Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan., Isaji S; Director of Mie University Graduate School of Medicine, Tsu, Japan., Tsuchida A; Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan., Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School Medicine, Yokohama, Japan.
Jazyk: angličtina
Zdroj: Journal of hepato-biliary-pancreatic sciences [J Hepatobiliary Pancreat Sci] 2022 Jul; Vol. 29 (7), pp. 725-731. Date of Electronic Publication: 2021 Oct 20.
DOI: 10.1002/jhbp.1049
Abstrakt: The symposium "New criteria of resectability for pancreatic cancer" was held during the 33nd meeting of the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) in 2021 to discuss the potential modifications that could be made in the current resectability classification. The meeting focused on setting the foundation for developing a new prognosis-based resectability classification that is based on the tumor biology and the response to neoadjuvant treatment (NAT). The symposium included selected experts from Western and Eastern high-volume centers who have discussed their concept of resectability status through published literature. During the symposium, presenters reported new resectability classifications from their respective institutions based on tumor biology, conditional status, pathology, and genetics, in addition to anatomical tumor involvement. Interestingly, experts from all the centers reached the agreement that anatomy alone is insufficient to define resectability in the current era of effective NAT. On behalf of the JSHBPS, we would like to summarize the content of the conference in this position paper. We also invite global experts as internal reviewers of this paper for intercontinental cooperation in creating an up-to-date, prognosis-based resectability classification that reflects the trends of contemporary clinical practice.
(© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
Databáze: MEDLINE
Externí odkaz: